Antiobesity drug therapy: An individualized and comprehensive approach.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 34341028.
- Also identified by DOI 10.3949/ccjm.88a.20080.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Obesity affects 42% of US adults and has a devastating impact on health. Although many patients initially lose weight with diet and exercise, long-term weight loss is difficult to achieve. Pharmacotherapy, as part of a comprehensive plan, can help patients lose weight and avoid regaining it. Choosing an antiobesity drug regimen should be an individualized, shared decision-making process that accounts for patient preferences, comorbidities, and out-of-pocket costs. We review antiobesity drugs and propose an individualized and comprehensive approach to obesity management.
Medical subject headings
- Anti-Obesity Agents